CLICK IN HERE TO DOWNLOAD

 

"The contemporary opioid crisis is widely seen as new and unprecedented. Not so. It is merely the latest in a long series of drug crises stretching back over a century. In&nbspWhite Market Drugs,&nbspDavid Herzberg explores these crises and the drugs that fueled them, from Bayer&#8217s Heroin to Purdue&#8217s&nbspOxyContin and all the drugs in between: barbiturate &#8220goof balls,&#8221 amphetamine &#8220thrill pills,&#8221 the &#8220love drug&#8221 Quaalude, and more. As Herzberg argues, the vast majority of American experiences with drugs and addiction have taken place within what he calls &#8220white markets,&#8221 &nbspwhere legal drugs called medicines are sold to a largely white clientele. These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its &#8220drug wars&#8221&#8212until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America&#8217s divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets to minimize risks while maintaining safe, reliable access (and treatment) for people with addiction. Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century. By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself&#8212ideas that have been failing us catastrophically for over a century.
"